TipRanks
Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
Germany Market
9IP1
Rocket Pharmaceuticals
RESEARCH TOOLSreports

Rocket Pharmaceuticals (9IP1) Balance Sheet

3 Followers

Rocket Pharmaceuticals Balance Sheet

Rocket Pharmaceuticals's total assets for Q2 2026 were $423.10M, an increase of 48.24% from the previous quarter. DE:9IP1 total liabilities were $54.27M for the fiscal quarter, a 14.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 330.45M$ 527.70M$ 566.34M$ 551.81M$ 497.02M
Total Liabilities
$ 53.23M$ 64.47M$ 73.77M$ 62.12M$ 42.30M
Total Equity Gross Minority
$ 277.22M$ 463.23M$ 492.57M$ 489.69M$ 454.72M
Other Metrics
Currency in USD

Rocket Pharmaceuticals Debt to Assets